Pagano et al identified risk factors for an invasive fungal infection (IFI) in a patient with a myeloproliferative neoplasm (MPN). These can help to identify a patient who may benefit from more aggressive management. The authors are members of SEIFEM (Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne) Group in Italy.